A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
The drug was named Science magazine’s 2024 “Breakthrough ... the efficacy of a twice-yearly subcutaneous injection of lenacapavir in preventing HIV infection among cisgender women; a second ...
Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring ... HIV Latency Reversing ...
What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...